Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
01093 CSPC PHARMA
7.000
-0.110-1.55%
YOY
Do not show
Hide blank lines
(Q6)2022/06/30(Q3)2022/03/31(FY)2021/12/31(Q9)2021/09/30
Turnover
12.93% 15.61B 16.94% 7.87B 11.73% 27.87B 7.42% 20.64B
Operating income
12.93% 15.61B 16.94% 7.87B 11.73% 27.87B 7.42% 20.64B
Cost of sales
-29.53% -4.27B -33.14% -2.06B -7.59% -6.73B -4.77% -4.99B
Operating expenses
-29.53% -4.27B -33.14% -2.06B -7.59% -6.73B -4.77% -4.99B
Gross profit
7.73% 11.34B 12.09% 5.81B 13.11% 21.14B 8.3% 15.66B
Selling expenses
-1.69% -5.41B -7.77% -2.82B -11.37% -10.44B -5.82% -7.78B
Administrative expenses
-13.64% -564.82M -20.08% -260.3M -6.78% -1.01B 0.5% -748.27M
Research and development expenses
-16.81% -1.88B -30.41% -901.52M -18.78% -3.43B -10.67% -2.51B
Operating interest expense
-- -- -- -- -- -- 20.26% -6.45M
Special items of operating profit
-54.52% 248.93M -148.06% -64.8M -6.64% 545.69M 829.34% 568.09M
Operating profit
2.38% 3.73B -1.68% 1.76B 12.19% 6.79B 25.18% 5.18B
Financing cost
-103.22% -9.72M -0.88% -2.86M 37.34% -7.66M -- --
Share of profits of associates
-38.43% -26.95M 38.39% -8.46M -14.23% -23.89M -73.08% -21.13M
Share of profit from joint venture company
32.14% 27.78M 46.54% 14.77M 34.51% 46.34M 17.92% 35.98M
Special items of earning before tax
-- -- -- -- -88.78% 37.37M -91.8% 24.27M
Earning before tax
1.54% 3.72B -1.13% 1.76B 7.14% 6.85B 17.23% 5.22B
Tax
-25.03% -692.38M -15.08% -329.63M 0.26% -1.16B 6.18% -824.85M
After-tax profit from continuing operations
-2.64% 3.03B -4.23% 1.43B 8.78% 5.69B 22.99% 4.4B
Earning after tax
-2.64% 3.03B -4.23% 1.43B 8.78% 5.69B 22.99% 4.4B
Minority profit
30.8% 60.88M 14.11% 29.77M 19.59% 82.94M 8.13% 61.76M
Profit attributable to shareholders
-3.15% 2.97B -4.55% 1.4B 8.63% 5.61B 23.23% 4.34B
Basic earnings per share
-2.85% 0.2489 -4.07% 0.1179 8.64% 0.4689 23.21% 0.3626
Diluted earnings per share
-2.85% 0.2489 -4.07% 0.1179 8.64% 0.4689 23.25% 0.3626
Currency Unit
CNYCNYCNYCNY
Accounting Standards
HKASHKASHKASHKAS
Audit Opinions
----Unqualified Opinion--
Auditor
----Deloitte-Guan Huang Chen Fang accountants--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Stone Pharmaceutical Group Co., Ltd. is an investment holding company mainly engaged in drug production and sales. The company sells its products under the brand name "Stone Medicine". The company includes four business divisions: proprietary medicine, antibiotics (intermediates and API), vitamin C (API) and caffeine and other (API), respectively engaged in the production and sales of related drugs. The company's proprietary medicines include antibiotics, cardio-cerebrovascular drugs, diabetes drugs, psychiatric drugs, antineoplastic drugs and traditional Chinese medicine products. Through its subsidiaries, the company is also engaged in providing drug research and development services and sewage and drug by-product treatment business.
CEO: Dongchen Cai
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top